Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04674683
Title Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Nivolumab in Patients With Advanced Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors HUYABIO International, LLC.
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | NZL | ITA | GBR | FRA | ESP | DEU | CZE | BRA | BEL | AUT | AUS


No variant requirements are available.